Kenji Mitsugi

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody

Hirofumi Ohmura, Fumiyasu Hanamura, Mamoru Ito et al. · British Journal of Cancer · 2020 · 87 citations · Full text

Life Sciences, Immunology, Oncology +17

Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells

Hiroshi Ariyama, Baoli Qin, Eishi Baba et al. · Journal of Cellular Biochemistry · 2005 · 66 citations

Medicine, Oncology, Pharmacology +17

Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.

Taito Esaki, S Nakano, Takashi Tatsumoto et al. · PubMed · 1992 · 61 citations

Medicine, Oncology, Pharmacology +15

<scp>PD</scp>‐1+ <scp>TIM</scp>‐3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer

Michitaka Nakano, Mamoru Ito, Risa Tanaka et al. · Cancer Science · 2018 · 45 citations · Full text

Life Sciences, Immunology, Oncology +17